How Vessels Work in Animals, Plants, and Bioengineering

Vessels are the body’s plumbing, but calling them that undersells how dynamic and varied they are. In humans, blood vessels form a closed network stretching tens of thousands of miles that delivers oxygen and nutrients to every living cell, while a separate set of lymphatic vessels quietly drains excess fluid and patrols for infection. Plants have their own version: xylem vessels that pull water from roots to leaves against gravity, sometimes over a hundred meters. Across biology, these tubes share a common job of moving fluid where it needs to go, yet the engineering solutions they use are wildly different.

How Blood Vessels Are Built

With the exception of the tiniest capillaries, every blood vessel in the body shares a three-layered wall design. The outermost layer, called the adventitia, provides structural support and anchors the vessel to surrounding tissue. The middle layer is a mix of elastic fibers and smooth muscle that controls how wide the vessel opens. The innermost layer is a single sheet of endothelial cells that gives blood a nearly frictionless surface to flow across. What changes from one type of vessel to another is the ratio of those ingredients.

Arteries sit closest to the heart and bear the highest pressure, so they are packed with elastic tissue. The largest arteries, like the aorta and pulmonary artery, are sometimes called elastic arteries because their walls stretch with each heartbeat and spring back between beats, smoothing out pressure spikes into a more continuous flow. Farther from the heart, arteries become more muscular and less elastic, giving the body finer control over how much blood reaches each organ. By the time blood reaches arterioles, the vessels are mostly smooth muscle and measure as little as eight micrometers across. These tiny muscular tubes are the main throttle for blood pressure: they widen or narrow in response to signals from the nervous system and from the tissues they feed.

Veins carry blood back toward the heart under much lower pressure. Their walls are thinner and less elastic, which lets them stretch and hold a large volume of blood at any given moment. Roughly two-thirds of total blood volume sits in the venous system at rest, making veins the body’s main blood reservoir. Many veins contain one-way valves that prevent backflow, a feature arteries do not need because the heart’s pumping pressure keeps arterial blood moving forward. Only about 10 to 15 percent of total blood volume is in the arterial system at any given time.

1PubMed. Anatomy, Blood Vessels

Capillaries and the Glycocalyx

Capillaries are the point of the whole system. Every artery branches and branches again until it reaches a capillary bed, where the vessel wall thins to a single layer of endothelial cells. That thinness is the feature, not a flaw: it lets oxygen, nutrients, and waste products pass back and forth between blood and tissue by simple diffusion. Capillary beds are so extensive that no cell in the body sits more than a few cell-widths away from one.

Coating the inner surface of these and all other blood vessels is a gel-like layer roughly 500 nanometers thick called the endothelial glycocalyx. For most of the twentieth century it was invisible to researchers, but since it was first observed in living tissue it has turned out to play several unexpected roles. It acts as a molecular sieve, influencing what crosses the vessel wall. It senses the mechanical drag of flowing blood, translating shear stress into biochemical signals inside the endothelial cells. And it helps regulate how white blood cells interact with the vessel wall during inflammation, since immune cells must push through the glycocalyx before they can attach and migrate into tissue.

2PubMed. The structure and function of the endothelial glycocalyx layer

How Vessels Control Their Own Diameter

Vessels are not passive pipes. They actively adjust their bore minute by minute, and the chief messenger molecule behind that adjustment is nitric oxide. Endothelial cells produce nitric oxide and release it into the smooth muscle wrapped around the vessel. It triggers the muscle to relax, widening the vessel and increasing blood flow. The same molecule also influences how much oxygen cells consume by acting on the energy-producing machinery inside mitochondria, so it affects both sides of the oxygen supply-and-demand equation at once.

3PubMed Central. Nitric oxide in the vasculature: where does it come from and where does it go? A quantitative perspective

When endothelial cells lose the ability to properly regulate vessel tone, the consequences cascade. Damaged or dysfunctional endothelium is one of the earliest steps in atherosclerosis. The cells stop maintaining the right balance of clotting factors, inflammatory signals, and antioxidants. Immune cells begin to stick to the vessel wall and burrow beneath it, setting up the chronic inflammation that eventually builds into a plaque. This process tends to strike at predictable spots, particularly at bends and branch points where blood flow is turbulent rather than smooth, suggesting that the mechanical environment of the vessel plays a direct role in which patches of endothelium become vulnerable.

4PubMed Central. Endothelial Cell Dysfunction and the Pathobiology of Atherosclerosis

How New Vessels Grow

The body does not stop building vessels after development. Whenever tissue is growing, healing, or starved for oxygen, it can call for new blood supply through a process called angiogenesis. The signal that kicks this off is a protein called VEGF, which acts as a chemical beacon. When a nearby tissue releases VEGF, a specialized endothelial cell at the tip of an existing vessel extends thin, finger-like projections called filopodia and begins crawling toward the signal. This “tip cell” does not divide; its job is navigation. The cells behind it, called stalk cells, are the ones that multiply and form the tube of the new vessel.

5PubMed Central. VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia

What keeps every cell from becoming a tip cell and racing off in different directions is a feedback loop. When a tip cell responds to VEGF, it activates a signal in its neighbors that suppresses tip-cell behavior, ensuring only a few leaders emerge while the rest stay behind and build. This interplay between tip and stalk cells is one reason tumors invest so heavily in manipulating VEGF: by flooding the area with the signal, they hijack angiogenesis to grow their own blood supply, which is why anti-VEGF drugs have become a pillar of cancer therapy.

6PubMed Central. VEGF and endothelial guidance in angiogenic sprouting

Lymphatic Vessels

Running alongside the blood vascular system is a second, less celebrated network: the lymphatic vessels. Unlike blood vessels, lymphatics are not a closed loop. They begin as blind-ended capillaries in nearly every tissue, collecting the fluid that leaks out of blood capillaries and would otherwise accumulate as swelling. This recovered fluid, now called lymph, is funneled through progressively larger vessels, filtered through lymph nodes (where immune cells sample it for threats), and eventually returned to the bloodstream near the heart.

7PubMed Central. Lymphatic Vessel Network Structure and Physiology

Beyond fluid balance, lymphatic vessels are the highways of the immune system. They carry immune cells and foreign particles from tissues to lymph nodes, making surveillance possible. Damage or blockage of lymphatic vessels, whether from surgery, infection, or genetic conditions, leads to chronic swelling known as lymphedema. More recently, researchers have discovered lymphatic vessels in places long thought to lack them, including the brain’s meninges, adding new chapters to how we understand waste clearance and immunity in the central nervous system.

8PubMed. Biological functions of lymphatic vessels

When Vessels Fail

Aneurysms represent a different mode of vessel failure from atherosclerosis. Rather than a plaque narrowing the vessel, an aneurysm is a ballooning outward, most dangerously in the abdominal aorta. The root cause is a breakdown of elastin, the protein that gives the aortic wall its ability to stretch and recoil. Enzymes called matrix metalloproteinases, particularly MMP-2 and MMP-9, chew through elastin and collagen. Their activity is amplified by chronic inflammation and oxidative stress, gradually weakening the wall until it dilates.

9PubMed Central. Elastin in the Pathogenesis of Abdominal Aortic Aneurysm 10PubMed Central. Matrix Metalloproteinase in Abdominal Aortic Aneurysm and Aortic Dissection

Because the process is slow and usually painless, many aneurysms go undetected until they are found incidentally on imaging or, in the worst case, when they rupture. Screening programs in several countries target older men who have ever smoked, the highest-risk group. No drug currently reverses an existing aneurysm; surgical repair with a synthetic graft or a stent is the treatment once the vessel reaches a critical diameter.

Vessels in the Brain

The brain’s capillaries behave differently from those elsewhere in the body. Their endothelial cells are stitched together with unusually tight junctions, and a supporting cast of cells called pericytes wraps around them and helps maintain the seal. Together these elements form the blood-brain barrier, which blocks most large molecules and pathogens from entering brain tissue while still allowing oxygen and glucose through. Pericytes contribute to this barrier partly by producing a signaling molecule called TGF-beta, which prompts the endothelial cells to tighten their connections.

11PubMed. Brain pericytes contribute to the induction and up-regulation of blood-brain barrier functions through transforming growth factor-beta production

This selectivity is vital for protecting neurons from toxins circulating in the blood, but it also makes treating brain diseases frustratingly difficult. Most drugs cannot cross the barrier on their own, which is why conditions like brain tumors and neurodegenerative diseases are so hard to treat pharmacologically. Strategies to temporarily open the barrier, deliver drugs encapsulated in nanoparticles, or piggyback drugs onto molecules that the barrier actively transports are all areas of intense research.

Fetal Vessels and the Switch at Birth

Before birth, blood vessels are plumbed in a fundamentally different arrangement. Because the fetus gets its oxygen from the placenta rather than its lungs, the circulatory system includes several temporary detours. A vessel called the ductus arteriosus shunts most blood away from the uninflated lungs and directly into the aorta. Another bypass, the ductus venosus, routes oxygenated blood from the umbilical vein past the liver. And an opening in the heart’s wall, the foramen ovale, lets oxygen-rich blood skip from the right side of the heart to the left without looping through the pulmonary circuit.

12PubMed. The transition from fetal to neonatal circulation: normal responses and implications for infants with heart disease

Within minutes of birth, this parallel arrangement must convert into the series circuit that adults use. The first breath inflates the lungs, which drops the resistance in pulmonary blood vessels dramatically and pulls blood into the lungs for the first time. Rising oxygen levels trigger the ductus arteriosus to constrict and eventually seal shut. The foramen ovale closes as pressure on the left side of the heart rises above the right. When any of these fetal shunts fails to close on schedule, the result is a congenital heart defect that may require medical or surgical intervention.

13Surgery. Basic Science Transition from fetus to neonate

Animal Vessels Built for Extremes

Giraffes face a hydraulic problem no other land animal shares: their heart must push blood roughly two meters upward to reach the brain, which generates enormous pressure in the lower legs. Their solution involves several layers of vascular engineering. Just below the elbow, the foreleg arteries abruptly thicken and narrow, functioning almost like built-in pressure reducers. The small arteries in the legs have a thicker muscular wall relative to their opening and develop far more contractile force than the same-sized arteries in the neck, measured at roughly 500 versus 318 mmHg in one study. On top of that, the tissue around the leg vessels has very low compliance, acting like a natural compression stocking that limits fluid from leaking into the interstitial space. These features appear in newborn giraffes as well, suggesting they are inherited rather than developed in response to a lifetime of high pressure.

14PubMed. Protection against high intravascular pressure in giraffe legs 15PubMed. Pressure profile and morphology of the arteries along the giraffe limb

Marine mammals deal with a different challenge: conserving heat in cold water. Whales, seals, and sea lions use a vascular structure called a rete mirabile, a tangle of small arteries and veins lying in close contact so that heat transfers from outgoing arterial blood to incoming venous blood. In the tongue of a gray whale, for example, cold blood returning from the surface passes right alongside warm arterial blood heading outward, recapturing heat before it is lost to the ocean. Seals use a similar counter-current system in their nasal passages to conserve heat and moisture during breathing, and in a network around the eyes.

16PubMed. Passive restriction of blood flow and counter-current heat exchange via lingual retia in the tongue of a neonatal gray whale Eschrichtius robustus (Cetacea, Mysticeti) 17Journal of Zoology. Anatomical and functional aspects of the nasal mucosal and ophthalmic retia of phocid seals

Deep-diving sea lions add another trick. Before a dive, they shunt arterial blood directly into veins through connections in their flippers, creating a highly oxygenated venous reservoir. This venous oxygen store, concentrated in a large abdominal vein called the hepatic sinus, helps sustain oxygen delivery during the portion of the dive when the lungs are collapsed and no gas exchange is happening.

18Journal of Experimental Biology. Anterior vena caval oxygen profiles in a deep-diving California sea lion: arteriovenous shunts, a central venous oxygen store and oxygenation during lung collapse

Xylem Vessels in Plants

Plants face a transport problem that looks impossible on paper: moving water from roots to the tops of tall trees without a pump. Xylem vessels, the dead, hollow tubes that carry water in woody plants, solve this using the cohesion-tension mechanism. As water evaporates from leaf surfaces, it creates a negative pressure that pulls on the continuous column of water molecules below, which cling to each other through hydrogen bonding. This column is under tension, essentially being pulled upward rather than pushed.

The system works remarkably well, but it is also fragile. If the tension exceeds a threshold, the water column can snap, forming an air bubble (an embolism) that blocks flow. Recently, researchers have found that xylem sap contains natural surfactants, molecules that coat tiny nanobubbles and hydrophobic surfaces inside the vessel, keeping bubbles below the critical size at which they would expand and break the water column.

19PubMed Central. Xylem Surfactants Introduce a New Element to the Cohesion-Tension Theory

When embolism does occur, recovery depends on the species and the severity. In Scots pine seedlings subjected to severe drought, embolized xylem showed no sign of refilling even four weeks after rewatering, indicating that for some conifers, the damage is permanent and the tree must grow new conducting tissue to restore flow.

20PubMed Central. Drought-Induced Xylem Embolism Limits the Recovery of Leaf Gas Exchange in Scots Pine

Maize roots, on the other hand, showed partial recovery after rewatering under low-light conditions, with refilled vessels regaining water columns at rates of roughly half a millimeter to over three millimeters per minute. Even so, refilling did not always restore actual sap flow, and the process appeared to work on an all-or-nothing basis within each vessel.

21PubMed. Functional repair of embolized vessels in maize roots after temporal drought stress, as demonstrated by magnetic resonance imaging

Engineering Artificial Vessels and Vessels-on-a-Chip

Replacing a damaged blood vessel with a synthetic one remains one of the harder problems in biomedical engineering, especially for small-diameter vessels under about six millimeters. Large-diameter grafts made of materials like Dacron and Teflon have been used for decades in procedures such as aortic repair, but small-diameter versions tend to clot or trigger excessive tissue growth that narrows the graft. One approach combines a natural scaffold, a donor vessel stripped of its cells, with a synthetic reinforcement layer of electrospun nanofibers and a heparin coating to resist clotting.

22PubMed. Hybrid small-diameter vascular grafts: Anti-expansion effect of electrospun poly ε-caprolactone on heparin-coated decellularized matrices

Building on that design, researchers have loaded the nanofiber layer with rapamycin, an immunosuppressive drug, so the graft slowly releases it to tamp down the overgrowth of smooth muscle cells inside the vessel that often causes small grafts to fail.

23PubMed. Hybrid electrospun rapamycin-loaded small-diameter decellularized vascular grafts effectively inhibit intimal hyperplasia

Meanwhile, microfluidic “vessel-on-a-chip” platforms let researchers study how endothelial cells behave under conditions that mimic the inside of a real blood vessel without needing animal models for every experiment. These chips recreate the shear stress, pulsatile flow, and cell-cell interactions of living vessels on a microscale. One recent platform achieved physiologically relevant shear stress levels at a fabrication cost about six times lower than commercial alternatives, making it practical for labs that could not previously afford such tools.

24PubMed. A cost-effective vessel-on-a-chip for high shear stress applications in vascular biology

These systems are already being used to study diseases like pulmonary arterial hypertension and thrombosis in real time, and they hold promise for screening drugs before they ever enter a living body. The technology is still young, limited by the difficulty of perfectly replicating the three-dimensional geometry and multi-cell-type architecture of a real vessel, but it is advancing quickly enough that it may reshape early-stage vascular research within the next decade.

25PubMed Central. Microfluidics in vascular biology research: a critical review for engineers, biologists, and clinicians